多病共存晚期慢性肾脏病老年患者准备接受响应式管理对比准备接受肾脏透析(Prepare for Kidney Care):一项随机对照试验的研究方案
本研究为两臂、优效性、平行组、非盲、个体水平、多中心、实用性随机对照试验,在英国国家医疗服务体系(NHS)肾脏中心开展,比较多病衰弱的晚期慢性肾脏病老年患者准备接受透析路径与准备接受保守肾脏管理路径对生存质量和数量的影响。主要结局为平均随访3年期间的质量调整生命年总数,主要分析为改良意向性治疗分析。
要点
- 纳入标准为晚期慢性肾脏病(估算肾小球滤过率<15 mL/min/1.73 m2,非急性肾损伤所致)且年龄≥80岁,或65-79岁伴衰弱或多病共存。
- 受试者按1:1随机分配至「准备接受响应式管理」(规范化的保守肾脏管理)或「准备接受肾脏透析」两组。
- 主要结局为平均随访3年期间的质量调整生命年总数,主要分析为改良意向性治疗分析。
核心结论
- 本研究旨在为多病衰弱晚期慢性肾脏病老年患者在准备透析与保守肾脏管理之间选择,以及为医疗专业人员和政策制定者规划相关服务提供高质量证据。
研究设计与样本
- 两臂、优效性、平行组、非盲、个体水平、多中心、实用性随机对照试验,在英国国家医疗服务体系(NHS)肾脏中心开展。
- 纳入晚期慢性肾脏病(估算肾小球滤过率<15 mL/min/1.73 m2,非急性肾损伤所致)且年龄≥80岁(不论衰弱或多病共存),或65-79岁伴衰弱或多病共存者。
- 受试者按1:1随机分配至「准备接受响应式管理」(规范化的保守肾脏管理)或「准备接受肾脏透析」。
- 包含整合的QuinteT招募干预。
主要发现
- 比较提示透析相较保守肾脏管理可能带来一定生存获益,但在80岁及以上、或存在多种健康问题或衰弱的人群中,这一获益可能以生活质量、住院、症状负担和首选死亡地点为代价。
关键数值与推荐
- 主要结局为平均随访3年期间的质量调整生命年总数。
- 主要分析为改良意向性治疗分析,纳入所有至少贡献一次生活质量测量的受试者。
- 次要结局包括生存、患者报告结局、身体功能、亲属/照护者报告结局以及治疗臂可接受性的定性评估。
- 成本效果从(i)NHS和个人社会服务及(ii)社会视角进行估计。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) prevalence is steadily increasing, in part due to increased multimorbidity in our aging global population. When progression to kidney failure cannot be avoided, people need unbiased information to inform decisions about whether to start dialysis, if or when indicated, or continue with holistic person-centred care without dialysis (conservative kidney management). Comparisons suggest that while there may be some survival benefit from dialysis over conservative kidney management, in people aged 80 years and over, or with multiple health problems or frailty, this may be at the expense of quality of life, hospitalisations, symptom burden and preferred place of death. Prepare for Kidney Care aims to compare preparation for a renal dialysis pathway with preparation for a conservative kidney management pathway, in relation to quantity and quality of life in multimorbid, frail, older people with advanced CKD. METHODS: This is a two-arm, superiority, parallel group, non-blinded, individual-level, multi-centre, pragmatic trial, set in United Kingdom National Health Service (NHS) kidney units. Patients with advanced CKD (estimated glomerular filtration rate < 15 mL/min/1.73 m2, not due to acute kidney injury) who are (a) 80 years of age and over regardless of frailty or multimorbidity, or (b) 65-79 years of age if they are frail or multimorbid, are randomised 1:1 to 'prepare for responsive management', a protocolised form of conservative kidney management, or 'prepare for renal dialysis'. An integrated QuinteT Recruitment Intervention is included. The primary outcome is mean total number of quality-adjusted life years during an average follow-up of 3 years. The primary analysis is a modified intention-to-treat including all participants contributing at least one quality of life measurement. Secondary outcomes include survival, patient-reported outcomes, physical functioning, relative/carer reported outcomes and qualitative assessments of treatment arm acceptability. Cost-effectiveness is estimated from (i) NHS and personal social services and (ii) societal perspectives. DISCUSSION: This randomised study is designed to provide high-quality evidence for frail, multimorbid, older patients with advanced CKD choosing between preparing for dialysis or conservative kidney management, and healthcare professionals and policy makers planning the related services. TRIAL REGISTRATION: ISRCTN, ISRCTN17133653 ( https://doi.org/10.1186/ISRCTN17133653 ). Registered 31 May 2017.
引用
- Worthington J, Soundy A, Frost J, et al. Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (Prepare for Kidney Care): Study protocol for a randomised controlled trial. Trials. 2024. PMID: 39420412. doi:10.1186/s13063-024-08509-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。